Recent Progress in Anticancer Agents Incorporating Pyrazole Scaffold

被引:47
|
作者
Mor, Satbir [1 ]
Khatri, Mohini [1 ]
Punia, Ravinder [1 ]
Sindhu, Suchita [1 ]
机构
[1] Guru Jambheshwar Univ Sci & Technol, Dept Chem, Hisar 125001, Haryana, India
关键词
Pyrazole; anticancer activity; EGFR; CDK inhibitor; anti-proliferation; apoptosis; telomerase; PRELIMINARY BIOLOGICAL EVALUATION; MICROWAVE-ASSISTED SYNTHESIS; DERIVATIVES BEARING PYRAZOLE; VITRO CYTOTOXIC ACTIVITY; POTENTIAL ANTICANCER; ANTIPROLIFERATIVE ACTIVITY; MOLECULAR DOCKING; IN-VITRO; INHIBITORY-ACTIVITY; ANTITUMOR-ACTIVITY;
D O I
10.2174/1389557521666210325115218
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The search for new anticancer agents is considered a dynamic field of medicinal chemistry. In recent years, the synthesis of compounds with anticancer potential has increased and a large number of structurally varied compounds displaying potent anticancer activities have been published. Pyrazole is an important biologically active scaffold that possesses nearly all types of biological activities. The aim of this review is to collate literature work reported by researchers to provide an overview on in vivo and in vitro anticancer activities of pyrazole based derivatives among the diverse biological activities displayed by them and also to present recent efforts made on this heterocyclic moiety regarding anticancer activities. This review has been driven by the increasing number of publications on this issue, which have been reported in the literature since the end of the 20th century (from 1995-to date).
引用
收藏
页码:115 / 163
页数:49
相关论文
共 50 条
  • [41] Titanocenes as Anticancer Agents: Recent Insights
    Skoupilova, Hana
    Hrstka, Roman
    Bartosik, Martin
    MEDICINAL CHEMISTRY, 2017, 13 (04) : 334 - 344
  • [42] Recent advances of benzimidazole as anticancer agents
    Venugopal, Sneha
    Kaur, Balwinder
    Verma, Anil
    Wadhwa, Pankaj
    Magan, Muskan
    Hudda, Sharwan
    Kakoty, Violina
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (02) : 357 - 376
  • [43] Medicinal attributes of pyridine scaffold as anticancer targeting agents
    Esraa Ali Mohamed
    Nasser S. M. Ismail
    Mohamed Hagras
    Hanan Refaat
    Future Journal of Pharmaceutical Sciences, 7
  • [44] A review of recent advances in anticancer activity and SAR of pyrazole derivatives
    Hofny, Heba A.
    Mohamed, Mamdouh F. A.
    Hassan, Heba A.
    Abdelhafez, El-Shimaa M. N.
    Abuo-Rahma, Gamal El-Din A.
    ARCHIV DER PHARMAZIE, 2025, 358 (03)
  • [45] Medicinal attributes of pyridine scaffold as anticancer targeting agents
    Mohamed, Esraa Ali
    Ismail, Nasser S. M.
    Hagras, Mohamed
    Refaat, Hanan
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)
  • [46] The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
    Nitulescu, George Mihai
    Stancov, Gheorghe
    Seremet, Oana Cristina
    Nitulescu, Georgiana
    Mihai, Dragos Paul
    Duta-Bratu, Cosmina Gabriela
    Barbuceanu, Stefania Felicia
    Olaru, Octavian Tudorel
    MOLECULES, 2023, 28 (14):
  • [47] Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR-Targeted Anticancer Agents
    Hosamani, Ketan R.
    Hemalatha, K.
    Pal, Rohit
    Matada, Gurubasavaraja Swamy Purawarga
    Kumaraswamy, B.
    Aayishamma, I
    Aishwarya, Nimmagadda Venkata Satya Sai
    CHEMISTRY & BIODIVERSITY, 2024, 21 (11)
  • [48] Recent Progress of Src SH2 and SH3 Inhibitors as Anticancer Agents
    Lu, X. -L.
    Cao, X.
    Liu, X. -Y.
    Jiao, B. -H.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (12) : 1117 - 1124
  • [49] Recent progress of protein kinase inhibitors derived from marine peptides for developing anticancer agents
    Zheng, Lanhong
    Wei, Ning
    Farooqi, Ammad Ahmad
    Zhang, Yan
    Blundell, Renald
    Liu, Xiujun
    Xu, Yixin
    Lin, Xiukun
    CELLULAR SIGNALLING, 2024, 124
  • [50] Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances
    Mateev, Emilio
    Georgieva, Maya
    Zlatkov, Alexander
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2022, 25 : 24 - 40